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ABSTRACT
The MUS81 protein belongs to a conserved family of DNA structure-specific 
nucleases that play important roles in DNA replication and repair. Inactivation 
of the Mus81 gene in mice has no major deleterious consequences for embryonic 
development, although cancer susceptibility has been reported. We have investigated 
the role of MUS81 in human cells by acutely depleting the protein using shRNAs. We 
found that MUS81 depletion from human fibroblasts leads to accumulation of ssDNA 
and a constitutive DNA damage response that ultimately activates cellular senescence. 
Moreover, we show that MUS81 is required for efficient replication fork progression 
during an unperturbed S-phase, and for recovery of productive replication following 
replication stalling. These results demonstrate essential roles for the MUS81 nuclease 
in maintenance of replication fork integrity.
INTRODUCTION
Faithful DNA replication is essential for the 
maintenance of genome stability in all organisms. The 
ability of cells to minimize transmission of errors arising 
during DNA replication to daughter cells depends not 
only on dedicated DNA replication factors, but also on 
a large number of DNA repair/DNA damage tolerance 
proteins. These genome maintenance proteins can act 
at a number of different locations during the replication 
process, including upstream of the advancing fork, 
within the replisome itself, or ‘post-replicatively’ behind 
the fork. Amongst the many replication fork repair 
factors are those that serve to stabilize, process or cleave 
replication forks stalled either by dNTP exhaustion [1, 2] 
or by an encounter with lesions/adducts in the template 
DNA [3, 4]. Failure to execute genome duplication in a 
timely or accurate manner can generate a cellular state 
often termed ‘replicative stress’. This state is associated 
with the accumulation of markers of replication-
associated DNA damage responses [5]. Importantly, in 
recent years it has become clear that replicative stress 
plays a key role during tumorigenesis [6–8]. Moreover, 
many solid cancers display evidence of persistent 
replicative stress [9, 10], and this phenotype is now 
widely considered to be an Achilles’ heel of tumor cells 
than can be exploited therapeutically [11, 12].
One process that plays a critical role in restoration of 
productive DNA synthesis at sites of stalled or collapsed 
replication forks is the homologous recombination 
repair (HRR) pathway [13]. HRR serves to restore 
replication following replication fork collapse after 
the fork encounters a ssDNA nick in the leading strand 
template, often through a process known as break-induced 
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replication (BIR) [14]. BIR is implicated in driving some 
cancer-associated events in that it can induce genomic 
duplications in human cells. HRR can also act post-
replicatively to fill ssDNA gaps that arise following 
replicative bypass of lesions on the lagging strand 
template. Interestingly, some of the factors that play a role 
in HRR also act directly on stalled replication forks outside 
the strict context of the HRR pathway. In human cells, 
these proteins include the MUS81 nuclease, the BLM 
helicase and a series of Fanconi anaemia pathway proteins. 
MUS81 is an evolutionarily conserved endonuclease that 
forms a complex with conserved interacting partners: 
Eme1 (in fission yeast) and Mms4 (in budding yeast) 
or either of the human EME1 and EME2 proteins [15]. 
These heterodimeric complexes are dual acting in yeasts, 
being involved both in resolving Holliday junction (HJ) 
structures during HRR [16, 17], and in processing stalled 
or otherwise disrupted replication forks [18, 19]. The 
human MUS81-EME1 and MUS81-EME2 complexes 
seem to function via a similar mechanism to their yeast 
orthologs [20, 21]. Mutation of either mus81+ or eme1+ 
in fission yeast causes very pronounced meiotic defects 
[17], although the phenotype is somewhat less severe in 
budding yeast. However, both budding and fission yeast 
mus81 mutants are sensitive to DNA replication perturbing 
agents, such as UV irradiation, methylmethane sulfonate 
(MMS), hydroxyurea (HU), and camptothecin (CPT) 
[19, 22–24], suggesting an important role of Mus81 and 
its partners in some aspect of replication fork repair. 
Surprisingly, however, Mus81−/−mice are viable and do 
not show obvious defects, apart from increased tumor 
incidence [25–27], despite the fact that embryo fibroblasts 
from these knockout mice accumulate chromosomal 
aberrations [25]. Nevertheless, Mus81 is known to be 
required for generation of double strand breaks (DSBs) 
following replication stalling in mouse embryonic 
stem (ES) cells, in a process that is probably required for 
re-initiation of productive replication [28] and cleavage of 
common fragile sites during mitosis [29, 30].
In order to investigate the phenotypic effect of 
acutely disabling a putative HJ resolvase and replication 
fork processing factor in human cells, and to analyze 
the subsequent cellular responses to replication stress, 
we have analyzed human cells in which MUS81 was 
depleted using shRNA. We demonstrate a critical role for 
MUS81 in maintaining DNA replication fork progression. 
Furthermore, spontaneous replication lesions caused by 
loss of MUS81 induce a DNA damage response, cell cycle 
arrest and subsequent cellular senescence.
RESULTS
Depletion of MUS81 leads to cell cycle arrest and 
senescence
To investigate a possible role for MUS81 in 
protecting DNA replication forks from irreversible 
breakdown, we used a previously validated adenoviral 
shRNA strategy to acutely deplete MUS81 from human 
U2OS cells [29]. Over a prolonged period of MUS81 
depletion (4–7 days), the MUS81 shRNA-expressing 
cells showed significant phenotypes, including a profound 
proliferation defect (Figure 1A). Specifically, we observed 
that these cells began to undergo cell cycle arrest 
following 4 days of lentiviral infection (Figure 1B) and 
became senescent within 7 days (Figure 1C). This process 
was accompanied by ATM-dependent up-regulation of 
the senescence-associated factor, p21 (Figure 2A and 2B). 
These experiments were performed using either 
of 2 independent shRNAs, and the extent of depletion of 
MUS81 was >90% in these cells within 48–72 hours of 
virus infection (Figure 2B and 2C). To analyze whether 
other features of a putative cell cycle checkpoint activation 
were evident in the MUS81-depeleted cells, we studied 
Figure 1: Depletion of MUS81 leads to proliferation arrest and cellular senescence. A. MUS81 depleted U2OS cells fail 
to proliferate further after 5 days of viral infection. The averages and standard deviations (error bars) from at least three experiments 
are depicted. B. Flow cytometric analysis showing a dramatic drop in the BrdU positive staining (replicating) cell population following 
depletion of MUS81. C. MUS81-depleted cells undergo senescence after 7 days of viral infection, as indicated by staining for senescence-
associated β-galactosidase (blue).
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activation of the CHK1 kinase, a defined marker of 
replication stress. We observed an increase in CHK1 
phosphorylation following MUS81-depletion (Figure 2C), 
consistent with the presence of spontaneous DNA damage/
replication stress in these cells.
A DNA damage response is triggered after 
depletion of MUS81
It has been reported that oncogene-induced 
senescence can occur via the activation of the DNA 
damage response triggered by persistent replicative stress 
[6, 31, 32]. To analyze whether the cellular senescence that 
we observed following depletion of MUS81 might also 
be due to DNA damage responses, we stained cells with 
antibodies against either NBS1 (a component of MRE11-
RAD50-NBS1 (MRN) complex) or the ssDNA binding 
protein, replication protein A (RPA). Multiple nuclear 
foci representing both NBS1 and RPA were evident in 
nearly 90% of MUS81-depleted cells (Figure 3A and 3B), 
indicative of a constitutive DNA damage response. 
About 40% NBS1 foci were shown to co-localize with 
RPA staining. To address whether the RPA foci represent 
regions of ssDNA, the MUS81-depleted cells were 
incubated in medium containing BrdU, and then stained 
with an antibody recognizing BrdU. This antibody is 
specific for BrdU in ssDNA, and hence no denaturation 
of the DNA is required to reveal BrdU incorporation. 
We found that the RPA foci strongly co-localized with 
BrdU positive foci (Figure 3C), indicating that the 
RPA foci almost exclusively define ssDNA regions. 
To investigate if the NBS1 foci are seen only during a 
specific cell cycle phase, Cyclin A protein was analyzed by 
immunofluorescence in order to specifically define S/G2 
phase cells. We observed that NBS1 foci were present 
in the MUS81-depleted cells regardless of their Cyclin 
A status (Figure 3D), suggesting that, even if these foci 
arise during a perturbed S-phase, they can persist in cells 
outside of S-phase.
It has been suggested that MUS81 may be involved 
in mediating telomeric recombination in ALT cells such 
as U2OS [33]. To address whether telomeres could be the 
source of a DNA damage signal that induces the formation 
of NBS1 foci, telomeres were labelled using FISH in the 
MUS81-depleted U2OS cells. We observed that the NBS1 
foci only rarely co-localized with telomeres, suggesting 
that the damage signal mainly originates from non-
telomeric loci (Figure 3E). We also asked if the NBS1 
foci seen in MUS81-depleted cells co-localize with PML 
protein. We found that nearly all PML bodies co-localized 
with NBS1 foci (Figure 3F). However, because there were, 
on average, far fewer PML bodies per cell than NBS1 
foci, the majority of NBS1 foci were not associated with 
a PML body.
MUS81 plays important roles in replication  
fork progression
One possible explanation for our results is that 
spontaneous lesions arising during DNA replication in 
the absence of MUS81 generate a DNA damage response, 
leading ultimately to cellular senescence. Consistent with 
this proposal, yeast mus81 mutants are hypersensitive to 
replication inhibiting agents [19, 22–24] and MUS81 has 
been shown to be involved in replication restart in mouse 
ES cells [28] as well as in resolution of replication stress-
induced common fragile site expression [29]. To investigate 
whether MUS81-depleted human cells show inherent 
problems during an unperturbed S-phase, or only a failure 
to efficiently restart stalled forks, we utilized the DNA fibre 
assay to visualize the progression of individual replication 
forks. We quantified replication fork progression in 
MUS81-depleted U2OS cells taken for analysis in the early 
stages of viral infection (3 days) before any signs of cellular 
Figure 2: A checkpoint activation is seen in MUS81-depleted cells. A. Western blot analysis of p21 and GRB2 protein levels 
after shRNA depletion of MUS81. Molecular masses are given in kDa. B. MUS81 depletion-mediated p21 induction is dependent on ATM. 
The AT5 cell line was derived from a patient with ataxia telangiectasia lacking ATM. Molecular masses are given in kDa. C. Western blot 
analysis of phospho-CHK1 (S317) and total CHK1 levels 3 days after shRNA depletion of MUS81. GRB2 is a loading control. Molecular 
masses are given in kDa.
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senescence were evident. Moreover, any cells that had 
ceased proliferation would not incorporate the nucleoside 
analogues used to mark sites of ongoing replication on 
the fibres and would, therefore, be eliminated from the 
analysis. Strikingly, we found that DNA replication fork 
speed was significantly reduced in the MUS81-depleted 
cells, being reduced to a level comparable to that of cells 
treated with an inhibitor of the CHK1 kinase (a known 
regulator of fork speed [2]) (Figure 4A–4C), indicating 
a fundamental requirement of MUS81 in DNA replication 
fork progression. Because this finding was surprising, given 
that MUS81 is a nuclease, and because of the possibility 
of potential off-target effects of the MUS81 shRNAs, we 
tested whether depletion of the MUS81 partner protein, 
EME1, also affected replication fork speed. We found 
that EME1 depletion also reduced fork speed significantly 
(Figure 4D and 4E), providing strong evidence that the 
effects on replication that we report are due to loss of 
MUS81-EME1 function and not to some off-target effect.
DISCUSSION
Using shRNA-mediated depletion, we have 
demonstrated that Mus81-depleted human cells display 
multiple abnormalities in DNA metabolism. These 
defects ultimately trigger a constitutive DNA damage 
Figure 3: Loss of MUS81 activates DNA damage response. A. MUS81 depleted U2OS cells accumulate NBS1 foci defining 
sites of DNA damage. B. Partial co-localization of NBS1 foci and RPA foci in MUS81-depleted cells. C. Co-localization of RPA foci to 
ssDNA regions. Cells were labelled with BrdU for 3 days concomitant with MUS81 depletion. BrdU was detected at ssDNA regions by 
immunofluorescence. D. NBS1 foci arise in cells that are both positive and negative for Cyclin A expression. Scale bars, 5 μm. E. NBS1 
foci form largely at non-telomeric loci. F. Partial co-localization of NBS1 foci with PML nuclear bodies.
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response, which we propose leads to MUS81-depleted 
cells undergoing cellular senescence. We report several 
abnormalities induced by depletion of MUS81 in U2OS 
cells. First, the cells accumulate multiple NBS1 and 
RPA foci, the latter of which form at sites of ssDNA 
accumulation, indicative of a DNA damage response. 
This occurs within 48 hours of exposure of the cells to 
MUS81 shRNA. At later times (5–7 days) the cells cease 
proliferation and show classical features of cellular 
senescence as might be expected because MUS81 is 
required for the maintenance of telomeres in cells such 
as U2OS that lack telomerase [33]. However, strikingly, 
the MUS81-depleted cells show abnormalities during 
S-phase that are genome-wide and not telomere specific. 
Replication fork progression is significantly impaired even 
in ‘undamaged’ cells. Perhaps surprisingly, the defect in 
constitutive replication fork movement is as severe as that 
seen in cells exposed to an inhibitor of the CHK1 kinase, 
a known regulator of fork speed [2].
Previous studies on Mus81−/− mice have suggested 
that loss of Mus81 function does not markedly affect 
embryonic development. Moreover, the adult mice are 
phenotypically quite normal, with the exception of an 
increase in the frequency of sporadic tumours [25, 26]. 
These results appear at odds with our findings using 
acute depletion of MUS81 in human cells in culture. 
Although the function of mouse and human MUS81 may 
not completely overlap [34], there are several possible 
explanations for this apparent discrepancy that we have 
considered. First, and most obviously, our data might 
reflect on off-target effect of the MUS81 shRNA that 
leads to depletion of another cellular factor. However, 
we consider this very unlikely, given that we see very 
similar effects using 2 independent shRNAs that share 
no sequence similarity or any obvious common target 
other than MUS81. Consistent with our interpretation, 
we previously reported that MUS81 depletion using 
these sequences suppressed SCEs in BS cells [29], as 
was reported by Wechsler et al., who used a different 
MUS81 shRNA sequence [35], and depletion of the 
MUS81 partner protein, EME1, also affected replication 
progression. A second possible explanation for our 
Figure 4: MUS81/EME1 controls replication progression speed. A. Following any indicated treatment, cells were  
pulse-labelled with CIdU and IdU for 20 min each. Distribution of replication fork speeds in cells treated as indicated. B. Representative images 
of replication tracks from cells expressing no shRNA or the MUS81 shRNA for 3 days. Also shown are cells exposed to the Chk1 inhibitor, 
CEP-3891, for 2 hours. C. The average replication speed at indicated conditions and standard deviations from at least three experiments 
D. Representative images of replication tracks from cells depleted with EME1 siRNA for 3 days. E. Distribution of replication fork speeds in 
cells following indicated treatment. The average speed and standard deviations from at least three experiments were shown on the top right.
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data is that the human cells used in our study show an 
intrinsically different response to replicative stress induced 
by MUS81 depletion than do mouse cells. This is possible, 
but it should be noted that MUS81 is highly conserved 
and plays roles in genome maintenance in many species, 
including yeasts. Our preferred explanation is that a 
mechanism exists for Mus81−/− mouse cells to ‘adapt’ to 
the loss of Mus81 protein over time that isn’t revealed 
when the protein is acutely depleted. It may be significant 
in this regard that targeting frequencies for the Mus81 
locus in mouse ES cells are very low [25]. This poor 
targeting efficiency may reflect a low frequency of genetic 
or epigenetic suppression of the Mus81 defect that permits 
rare survivors of the targeting regimen to be recovered.
The most striking effect of MUS81 depletion 
is to cause a reduction in the rate of replication fork 
progression, a finding also observed following depletion 
of EME1. Hence, we must consider how a nuclease such 
as MUS81 might affect replication fork progression. 
It seems very unlikely that MUS81 plays a direct role 
in DNA synthesis per se. Instead, we favour the view 
that certain aspects of natural fork movement through a 
DNA double helix might create a periodic requirement 
for MUS81 to act. One possibility is that MUS81 is 
required to reactivate forks that have stalled for some 
reason. A second, related possibility is that MUS81 acts 
at sites where an atypical DNA structure has arisen during 
replication fork progression. Given that MUS81 can cleave 
4-way DNA structures resembling Holliday junctions, it is 
possible that a failure to have prompt relief of torsional 
stress ahead of the advancing replication fork causes the 
fork to periodically reverse (so-called fork regression), 
generating a 4-way DNA junction. Indeed, recent data 
indicate that fork regression is a remarkably frequent 
event in human cells [36]. MUS81 might be required to 
cleave such regressed forks in order to permit restoration 
of normal fork progression. If this proposal is relevant 
to the phenotype we have observed by chromosome 
fiber analysis, the underlying problem must occur quite 
frequently in the genome during S-phase because the 
average fork speed was consistently reduced in the 
multiple fibers that we analyzed. A further possibility is 
that, at least under some circumstances, MUS81 itself acts 
to relieve the torsional stress induced by the replication 
fork movement. Although, this role is primarily performed 
by certain DNA topoisomerases [37], some situations 
might necessitate the ssDNA-nicking activity of MUS81 
to relieve the stress.
We propose a model in order to explain the observed 
senescence induced following MUS81 depletion. We 
suggest that reduced replication fork progression 
in MUS81-depleted cells result in accumulation 
of replication-associated ssDNA. Such unresolved 
replication structures are the likely source of the signal 
for the activation of the ATR-Chk1 DNA damage response 
pathway, mediated through ATRIP binding to RPA [38]. It 
is well established that extended DNA damage signaling 
following replication stress can induce cellular senescence 
[6, 31, 32].
A previous study [33] reported, as we do, that 
MUS81 depletion from human ALT cells leads to growth 
arrest. We have extended this to show that the cells 
undergo replicative senescence that is accompanied by a 
strong DNA damage response. The most straightforward 
explanation for this would be that telomere instability 
elicits a signal that activates the formation of foci 
containing DNA damage/repair factors. However, we 
found only a modest degree of co-localization between 
the foci containing NBS1 and RPA, and sites of telomeric 
stress. Coupled with the fact that we have defined a 
general defect in replication fork progression in MUS81-
depleted cells, we suggest that telomeres cannot be the 
sole source of the DNA damage signal that induces growth 
arrest in cells with impaired MUS81 function.
In summary, we have shown that acute and severe 
depletion of MUS81 from human cells in culture elicits 
a constitutive DNA damage response that is associated 
with intrinsic defects in DNA replication fork progression 
and ultimately leads to cellular senescence. A plethora 
of cell cycle checkpoint and DNA repair mechanisms 
have evolved in order to safeguard genome integrity 
in a coordinated fashion with DNA replication. Loss 
of any of these mechanisms promotes the development 
of ‘chromosome instability’ disorders, and often an 
increased risk of cancer [39]. Mus81−/− mice have a 
predisposition to the development of spontaneous 
lymphomas, breast cancer and prostate cancer compared 
to haploinsufficient Mus81 mice [26, 27, 40]. Moreover, 
Mus81−/− p53-/- double mutant mice develop excess 
sarcomas [27] and Blm−/− Mus81−/− double mutant mice 
show significantly increased risk of tumour development 
compared with single mutants [41]. Reduced MUS81 
expression has also been observed in human carcinomas 
including hepatocellular carcinoma [42] and colon 
carcinoma [43], and this is associated with poor 
prognosis. Moroever, single nucleotide polymorphisms in 
human MUS81 that reduce protein activity are a proposed 
breast cancer susceptibility factor [44]. Taken together, 
these data indicate that MUS81 is a tumor suppressor 
gene and plays a role in suppressing the development of 
different malignancies [25–27, 40].
MATERIALS AND METHODS
Cell culture and RNA interference
Normal human fibroblasts, GM00637 and ATM-
deficient fibroblasts (AT5) cells were grown in Minimum 
Essential Medium (MEM) Alpha Medium, while U2OS 
cells were grown in Dulbecco’s modified Eagle’s medium 
(DMEM) with 10% fetal bovine serum at 37°C under 
an atmosphere containing 5% CO2. The Chk1 inhibitor 
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CEP-3891 was provided by Cephalon Inc., and was used at 
a concentration of 500 nM, as described previously [2]. To 
deplete human MUS81, the following shRNAs were used: 
shMUS81-a (5′-GAGTTGGTACTGGATCACATT-3′); 
shMUS81-b (5′-CCTAATGGTCACCACTTCTTA-3′). 
Pooled GeneSolution siRNA against EME1 was purchased 
from Qiagen (5′-CACAGCCA GTCAGGTTGCTAA-3′; 
5′-GAGGAGTGCAGCAGATAACAA-3′; 
5′-CAGAATTTGCTC GCAGACATA-3′; 
5′-AAGGACCTGATCTTAGATCCA-3′).
Immunofluorescence and FISH
Following any indicated treatment, cells were fixed 
and stained as described previously [45]. The primary 
antibodies used were against NBS1 (1:1000, NB100–143, 
Novus), RPA (1:1000, ab2175, Abcam), PML (1:1000, 
ab94471, Abcam) and Cyclin A (1:200, sc-56299, Santa 
Cruz). The secondary antibodies were AlexaFluor 488 or 
555-conjugated goat anti-rabbit or anti-mouse IgG (1:500, 
all from Life Technologies).
For combined immunofluorescence and FISH, 
samples were exposed to the appropriate primary 
and secondary antibodies (as above) and subjected to 
re-fixation in paraformaldehyde (8%) at 4°C for 20 min. 
A telomere PNA FISH kit (DakoCytomation) was used 
to detect telomeres. Samples were denatured at 80°C 
for 3 min under a coverslip in the presence of the Cy3-
conjugated PNA probe. Slides were then hybridized in 
the dark at room temperature for 30 min, followed by a 
brief rinse and a post-hybridization wash with a wash 
solution at 65°C for 5 min. DNA was counterstained 
with DAPI.
Western blotting
Cells were lysed in RIPA buffer in the presence 
of 1 × protease inhibitor cocktail (Sigma). An aliquot 
of 50 μg total protein was run on an SDS-PAGE gel and 
transferred to Hybond ECL membrane (GE Healthcare). 
This membrane was immuno-blotted with antibodies 
against MUS81 (1:1000, ab14387, Abcam), GRB2 
(1:1000, 610112, BD Transduction Laboratories), 
p21 (1:1000, 2947, Cell Signaling Technologies), 
phospho-CHK1 (pS317, 1:1000, A300–163A, Bethyl), 
CHK1 (1:1000, sc-7898, Santa Cruz), and Actin (1:5000, 
A2547, Sigma). Immuno-reactive proteins were visualized 
using ECL reagents (Roche) following the manufacturer’s 
instructions.
Cell proliferation assays
Cells were infected with adenoviruses carrying 
the indicated shRNA in a multiwell plate, and the cell 
proliferation was measured as described elsewhere 
[46, 47]. Each day 4 after infection, cells in one well were 
counted with a haemocytometer.
FACS analysis
Cells were pulse-labelled with BrdU (20 μM) 
for 30 min before harvesting. Following fixation in 
70% ethanol and denaturation in HCl (2 M), cells were 
stained with a mouse monoclonal antibody against BrdU 
(BD Biosciences). After staining with a fluorescence-
conjugated secondary antibody, cells were analysed using 
a FACSCalibur Flow Cytometer (Becton Dickinson).
Measurement of cellular senescence
Cellular senescence was determined using a 
Senescence Staining Kit (Cell Signaling Technologies) 
following instructions provided by the manufacturer. 
Following the indicated treatments, cells were fixed and 
stained for the presence of β-Galactosidase using the 
staining solution supplied. The solution was removed 
when a blue colour had developed and 70% glycerol was 
added for long-term sample storage.
DNA Fibre assays
Cells were pulse-labeled with 25 μM CIdU for 
20 min, washed 3 times with medium, and then incubated 
in 2 mM HU for 2 hours. After washing with medium, 
250 μM IdU was added for 20 min. Labelled cells were 
harvested and DNA fibre spreads were prepared as 
described previously [48]. For immunodetection of CIdU-
labelled tracts, acid-treated fibre spreads were incubated 
with a rat anti-BrdU monoclonal antibody (AbD Serotec) 
that recognises CIdU, but not IdU, for 1 hour at room 
temperature. Slides were fixed with 4% formaldehyde, and 
were then incubated with an AlexaFluor 555-conjugated 
goat anti-rat IgG (Life Technologies) for 1.5 hour at 
room temperature. IdU-labelled patches were detected 
using a mouse anti-BrdU monoclonal antibody (Becton 
Dickinson) that recognises IdU, but not CIdU, by 
incubation overnight at 4ºC, followed by incubation 
with an AlexaFluor 488-conjugated goat anti-mouse 
F(ab’)2 fragment (Life Techologies) for 1.5 hour at room 
temperature. Fibres were examined using a using a Biorad 
Radiance confocal microscope using a 60 × (1.3 NA) 
lens. The lengths of CIdU (AF 555, red) and IdU (AF 488, 
green) labelled tracts were measured using the ImageJ 
software, and values of tract length were converted into 
DNA kilobases using the conversion factor 1 μm = 2.59 kb 
[48]. Replication structures were quantified using the Cell 
Counter Plug-in for ImageJ (Kurt De Vos, University of 
Sheffield, UK).
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